Answers are grounded in this paper and cite their sources.
Confirms J-FTE7366 SNP's accessibility in various Y chromosome regions, indicating significant genomic visibility across platforms.
Every haplogroup name points to a specific mutation at a specific location on the Y chromosome. Here is exactly where J-FTE7366 sits across every reference genome. • T2T (CHM13v2.0): chrY:10,279,929, Yp11.2 • GRCh38/HG38: chrY:9,960,846 • GRCh37/HG19: chrY:9,798,455 J-FTE7366 sits on the short arm of the Y chromosome in the Yp11.2 region. It is fully accessible to all reference assemblies. Any Big Y test can reach it. Any Whole Genome Sequence can reach it. No special re-alignment is required. This stands in direct contrast to the two T2T-exclusive SNPs documented below it, J-Y637739 and J-Y637789, which sit on the long arm in the Yq11.223 ampliconic palindrome zone with no coordinate in either GRCh37 or GRCh38, and J-Y637804, sitting even further out in Yq12 at the distal tip of the long arm, also invisible to all prior assemblies. One lineage. Three regions of the Y chromosome. From the short arm to the very end of the long arm. Each one telling a different story about what current and past reference assemblies can and cannot see.
No takes yet. Share an insight, caveat, or question.
Thomas James Johnson III Vincek (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: